These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36929319)

  • 1. Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa.
    Malahleha M; Laher F; Dilraj A; Smith P; Gray GE; Grove D; Odhiambo JA; Andrasik MP; Grunenberg NA; Moodie Z; Huang Y; Borate BR; Gillespie KM; Allen M; Atujuna M; Singh N; Kalonji D; Meintjes G; Kotze P; Bekker LG; Janes H
    AIDS Behav; 2023 Sep; 27(9):3027-3037. PubMed ID: 36929319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participants' characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa.
    Hanass-Hancock J; Carpenter B; Reddy T; Nzuza A; Gaffoor Z; Goga A; Andrasik M
    Trials; 2021 Dec; 22(1):897. PubMed ID: 34895272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa.
    Otwombe KN; Sikkema KJ; Dietrich J; de Bruyn G; van der Watt M; Gray GE
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):211-8. PubMed ID: 21765362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.
    Moodie Z; Metch B; Bekker LG; Churchyard G; Nchabeleng M; Mlisana K; Laher F; Roux S; Mngadi K; Innes C; Mathebula M; Allen M; Bentley C; Gilbert PB; Robertson M; Kublin J; Corey L; Gray GE
    PLoS One; 2015; 10(9):e0137666. PubMed ID: 26368824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth.
    Price MA; Rida W; Mwangome M; Mutua G; Middelkoop K; Roux S; Okuku HS; Bekker LG; Anzala O; Ngugi E; Stevens G; Chetty P; Amornkul PN; Sanders EJ
    J Acquir Immune Defic Syndr; 2012 Feb; 59(2):185-93. PubMed ID: 22227488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.
    Gray GE; Moodie Z; Metch B; Gilbert PB; Bekker LG; Churchyard G; Nchabeleng M; Mlisana K; Laher F; Roux S; Mngadi K; Innes C; Mathebula M; Allen M; McElrath MJ; Robertson M; Kublin J; Corey L;
    Lancet Infect Dis; 2014 May; 14(5):388-96. PubMed ID: 24560541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial.
    Mpofu R; Otwombe K; Mlisana K; Nchabeleng M; Allen M; Kublin J; McElrath MJ; Bekker LG; Churchyard G; Gray G; Laher F
    PLoS One; 2021; 16(1):e0241708. PubMed ID: 33481787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV incidence and predictors of inconsistent condom use among adult men enrolled into an HIV vaccine preparedness study, Rustenburg, South Africa.
    Maenetje P; Lindan C; Makkan H; Chetty-Makkan CM; Latka MH; Charalambous S; Mlotshwa M; Malefo M; Brumskine W; Hills NK; Price MA; Edward V
    PLoS One; 2019; 14(4):e0214786. PubMed ID: 30943254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.
    Moodie Z; Dintwe O; Sawant S; Grove D; Huang Y; Janes H; Heptinstall J; Omar FL; Cohen K; De Rosa SC; Zhang L; Yates NL; Sarzotti-Kelsoe M; Seaton KE; Laher F; Bekker LG; Malahleha M; Innes C; Kassim S; Naicker N; Govender V; Sebe M; Singh N; Kotze P; Lazarus E; Nchabeleng M; Ward AM; Brumskine W; Dubula T; Randhawa AK; Grunenberg N; Hural J; Kee JJ; Benkeser D; Jin Y; Carpp LN; Allen M; D'Souza P; Tartaglia J; DiazGranados CA; Koutsoukos M; Gilbert PB; Kublin JG; Corey L; Andersen-Nissen E; Gray GE; Tomaras GD; McElrath MJ
    J Infect Dis; 2022 Aug; 226(2):246-257. PubMed ID: 35758878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africa.
    Laher F; Otwombe K; Mokwena O; Bekker LG; Allen M
    AIDS Behav; 2023 Apr; 27(4):1314-1320. PubMed ID: 36287343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of HIV-related risk behaviors among self-identified heterosexual men who have sex with men (HMSM): national survey of family growth (2002, 2006-2010, and 2011-2017).
    Abdallah I; Conserve D; Burgess TL; Adegbite AH; Oraka E
    AIDS Care; 2020 Dec; 32(12):1529-1537. PubMed ID: 32024380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
    Bekker LG; Moodie Z; Grunenberg N; Laher F; Tomaras GD; Cohen KW; Allen M; Malahleha M; Mngadi K; Daniels B; Innes C; Bentley C; Frahm N; Morris DE; Morris L; Mkhize NN; Montefiori DC; Sarzotti-Kelsoe M; Grant S; Yu C; Mehra VL; Pensiero MN; Phogat S; DiazGranados CA; Barnett SW; Kanesa-Thasan N; Koutsoukos M; Michael NL; Robb ML; Kublin JG; Gilbert PB; Corey L; Gray GE; McElrath MJ;
    Lancet HIV; 2018 Jul; 5(7):e366-e378. PubMed ID: 29898870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.
    Gray GE; Allen M; Moodie Z; Churchyard G; Bekker LG; Nchabeleng M; Mlisana K; Metch B; de Bruyn G; Latka MH; Roux S; Mathebula M; Naicker N; Ducar C; Carter DK; Puren A; Eaton N; McElrath MJ; Robertson M; Corey L; Kublin JG;
    Lancet Infect Dis; 2011 Jul; 11(7):507-15. PubMed ID: 21570355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV burden and correlates of infection among transfeminine people and cisgender men who have sex with men in Nairobi, Kenya: an observational study.
    Smith AD; Kimani J; Kabuti R; Weatherburn P; Fearon E; Bourne A
    Lancet HIV; 2021 May; 8(5):e274-e283. PubMed ID: 33631101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterosexual anal intercourse and HIV infection risks in the context of alcohol serving venues, Cape Town, South Africa.
    Kalichman SC; Pinkerton SD; Carey MP; Cain D; Mehlomakulu V; Carey KB; Simbayi LC; Mwaba K; Harel O
    BMC Public Health; 2011 Oct; 11():807. PubMed ID: 21999574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru.
    Andrasik M; Grove D; Broder G; Scott H; Allen M; Karuna S
    Vaccine; 2019 Jun; 37(29):3911-3917. PubMed ID: 31176538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans.
    Zhao LP; Fiore-Gartland A; Carpp LN; Cohen KW; Rouphael N; Fleurs L; Dintwe O; Zhao M; Moodie Z; Fong Y; Garrett N; Huang Y; Innes C; Janes HE; Lazarus E; Michael NL; Nitayaphan S; Pitisuttithum P; Rerks-Ngarm S; Robb ML; De Rosa SC; Corey L; Gray GE; Seaton KE; Yates NL; McElrath MJ; Frahm N; Tomaras GD; Gilbert PB
    PLoS One; 2020; 15(1):e0226803. PubMed ID: 31999736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women.
    Latka MH; Fielding K; Gray GE; Bekker LG; Nchabeleng M; Mlisana K; Nielson T; Roux S; Mkhize B; Mathebula M; Naicker N; de Bruyn G; Kublin J; Churchyard GJ;
    PLoS One; 2012; 7(4):e31387. PubMed ID: 22532824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transactional sex among young women in rural South Africa: prevalence, mediators and association with HIV infection.
    Ranganathan M; Heise L; Pettifor A; Silverwood RJ; Selin A; MacPhail C; Delany-Moretlwe S; Kahn K; Gómez-Olivé FX; Hughes JP; Piwowar-Manning E; Laeyendecker O; Watts C
    J Int AIDS Soc; 2016; 19(1):20749. PubMed ID: 27469061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya.
    Jackson DJ; Martin HL; Bwayo JJ; Nyange PM; Rakwar JP; Kashonga F; Mandaliya K; Ndinya-Achola JO; Kreiss JK
    AIDS; 1995 Nov; 9(11):1279-83. PubMed ID: 8561982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.